212 related articles for article (PubMed ID: 21535073)
1. Growth hormone is positively associated with surrogate markers of bone turnover during puberty.
Russell M; Breggia A; Mendes N; Klibanski A; Misra M
Clin Endocrinol (Oxf); 2011 Oct; 75(4):482-8. PubMed ID: 21535073
[TBL] [Abstract][Full Text] [Related]
2. Bone metabolism markers and bone mass in healthy pubertal boys and girls.
van Coeverden SC; Netelenbos JC; de Ridder CM; Roos JC; Popp-Snijders C; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 2002 Jul; 57(1):107-16. PubMed ID: 12100078
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of bone turnover in girls during puberty.
Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone suppression after an oral glucose load in children.
Misra M; Cord J; Prabhakaran R; Miller KK; Klibanski A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4623-9. PubMed ID: 17878248
[TBL] [Abstract][Full Text] [Related]
5. Peptide YY levels across pubertal stages and associations with growth hormone.
Lloyd B; Ravi P; Mendes N; Klibanski A; Misra M
J Clin Endocrinol Metab; 2010 Jun; 95(6):2957-62. PubMed ID: 20375207
[TBL] [Abstract][Full Text] [Related]
6. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.
Clark PA; Clarke WL; Pedadda S; Reiss A; Langlois C; Nieves-Rivera F; Rogol AD
J Pediatr Endocrinol Metab; 1998; 11(3):427-35. PubMed ID: 11517959
[TBL] [Abstract][Full Text] [Related]
7. Effects of usual nutrient intake and vitamin D status on markers of bone turnover in Swiss adolescents.
Ginty F; Cavadini C; Michaud PA; Burckhardt P; Baumgartner M; Mishra GD; Barclay DV
Eur J Clin Nutr; 2004 Sep; 58(9):1257-65. PubMed ID: 15054442
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys.
Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
[TBL] [Abstract][Full Text] [Related]
10. Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial.
Berger PK; Pollock NK; Laing EM; Chertin V; Bernard PJ; Grider A; Shapses SA; Ding KH; Isales CM; Lewis RD
J Nutr; 2015 Dec; 145(12):2699-704. PubMed ID: 26491117
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
[TBL] [Abstract][Full Text] [Related]
12. The relationship between circulating hormone levels, bone turnover markers and skeletal development in healthy boys differs according to maturation stage.
Banica T; Vandewalle S; Zmierczak HG; Goemaere S; De Buyser S; Fiers T; Kaufman JM; De Schepper J; Lapauw B
Bone; 2022 May; 158():116368. PubMed ID: 35181575
[TBL] [Abstract][Full Text] [Related]
13. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the GH/IGF-I axis and serum markers of bone turnover metabolism in healthy children.
Léger J; Mercat I; Alberti C; Chevenne D; Armoogum P; Tichet J; Czernichow P
Eur J Endocrinol; 2007 Nov; 157(5):685-92. PubMed ID: 17984250
[TBL] [Abstract][Full Text] [Related]
15. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
[TBL] [Abstract][Full Text] [Related]
16. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
Gürlek A; Gedik O
J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
[TBL] [Abstract][Full Text] [Related]
17. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
[TBL] [Abstract][Full Text] [Related]
19. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
[TBL] [Abstract][Full Text] [Related]
20. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins.
Scacchi M; Danesi L; Cattaneo A; Sciortino G; Radin R; Ambrogio AG; Vitale G; D'Angelo E; Mirra N; Zanaboni L; Arvigo M; Boschetti M; Ferone D; Marzullo P; Baldini M; Cassinerio E; Cappellini MD; Persani L; Cavagnini F
Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
